Impact of COVID-19 on corticosteroids and antibiotics prescribing in England: an interrupted time series analysis | Zendy

Christos V. Chalitsios | Zendy; Tricia M. McKeever | Zendy; Tessa Langley | Zendy; Dominick Shaw | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Impact of COVID-19 on corticosteroids and antibiotics prescribing in England: an interrupted time series analysis

Author(s) -

Christos V. Chalitsios,

Tricia M. McKeever,

Tessa Langley,

Dominick Shaw

Publication year - 2021

Publication title -

journal of public health

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.916

H-Index - 82

eISSN - 1741-3850

pISSN - 1741-3842

DOI - 10.1093/pubmed/fdab017

Subject(s) - medicine , pandemic , medical prescription , covid-19 , declaration , outbreak , prednisolone , inhaled corticosteroids , public health , intensive care medicine , pediatrics , emergency medicine , asthma , virology , infectious disease (medical specialty) , pharmacology , disease , nursing , political science , law

Inhaled corticosteroids (ICS), prednisolone and antibiotics all play a crucial role in the management of respiratory diseases. The aim of this study was to analyse whether the declaration of the COVID-19 pandemic affected prescribing rates, as public health measures were implemented to reduce transmission of SARS-CoV-2. Monthly practise-level prescribing data published by NHS Digital were analysed. At the point, the COVID-19 outbreak was declared a pandemic, ICS prescriptions rose significantly. This was followed by a decrease in ICS and prednisolone prescribing in the following months. There was no difference in the antibiotic prescribing trend.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research